Skip To Main Content
Nicholas Hunt on Muck Rack

Nicholas Hunt

As seen in: Nature, British Pharmacological Society, The Atlantic, MDPI, Slate, Outside Magazine, New Atlas, SPIN, The FADER, Truthout and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nicholas

Contact Nicholas, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Liver, ageing and disease - Nature Reviews Gastroenterology & Hepatology

|
By Nicholas Hunt, Stephen Simpson, Meng C. Ngu
| Nature Verified
Abstract As the global population ages, research on the biology of ageing and its role in chronic disease is expanding, alongside a growing clinical focus on the unique needs of older adults. In the past, the liver was not thought to undergo substantial age-related changes, nor was there thought to be any liver disease characteristic of older adults.
Open in Who Shared Issue with article?

Understanding the Liver’s Role in the Clearance of Aβ40

|
By Glen P. Lockwood, Nicholas Hunt, Maaike Kockx, Victoria C. Cogger
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Oral insulin set for human trials in 2025, may be available in 2-to-3 years Original

|
By Nicholas Hunt, Paul McClure
| New Atlas Verified
Researchers who’ve developed an oral insulin that has proven effective at reducing blood glucose and avoiding hypoglycemia in mice, rats, and baboons are set to take their drug to human clinical trials as soon as 2025. They’re hopeful it’ll be available to all in a few years. New Atlas has covered a lot of research into oral insulin, from its development to testing in both animal and human trials.
Open in Who Shared View Duplicates (4) Issue with article?
See all 52 licensed articles (58 Total)